Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| lhrh prostate cancer |
|
Methods for treating prostate cancer with LHRH antagonists Methods for treating prostate cancer are disclosed. The methods of the invention generally feature administration to a subject of an LHRH antagonist, Methods for treating prostate cancer with LHRH-R antagonists - US Methods for treating prostate cancer with LHRH-R antagonists - US Patent 6153586 from Patent Storm. Methods for treating prostate cancer are disclosed. European Urology : Hormone Therapy in Prostate Cancer: LHRH A total of 242 patients with prostate cancer requiring initial hormonal treatment received abarelix depot (n = 209) or LHRH agonists (n = 33) with or Combination of a long-acting delivery system for luteinizing The inhibition of growth caused by the D-Trp6LH-RH microcapsules alone (672 +/- Treatment of newly diagnosed metastatic prostate cancer patients with Bone loss associated with the use of LHRH agonists in prostate cancer When patients with advanced prostate cancer are treated with luteinising hormone releasing hormone (LHRH) agonist analogues their circulating testosterone IngentaConnect Climacteric-Like Disorders in Prostate Cancer Sixty-four prostate cancer patients treated with LHRH agonists and 30 benign prostatic hyperplasia patients, as a control group, were surveyed by IngentaConnect LHRH agonists in prostate cancer: frequency of LHRH agonists in prostate cancer: frequency of treatment, serum testosterone measurement and castrate level: consensus opinion from a roundtable discussion Prostate Cancer Info : education, support, male hormone therapy Prostate cancer may start to progress after patients have been on combined antiandrogen blockade therapy (therapy with an LHRH analog and an antiandrogen or LH-RH agonists/GnRH agonists for prostate cancer - Yahoo! Health Luteinizing hormone-releasing hormone (LH-RH) agonists and gonadotropin-releasing hormone (GnRH) agonists are drugs that decrease the production of LH-RH agonists/GnRH agonists for prostate cancer - Medication Example(s): Suprefact (buserelin acetate), Zoladex (goserelin acetate), Lupron, Eligard (leuprolide acetate), Trelstar (triptorelin pamoate) LH-RH agonists/GnRH agonists for prostate cancer - Medication Example(s): Zoladex (goserelin acetate), Lupron (leuprolide acetate), Trelstar Depot (triptorelin pamoate) eMedicine - Prostate Cancer: Metastatic and Advanced Disease Garnick MB, Campion M: Abarelix Depot, a GnRH antagonist, v LHRH superagonists in prostate cancer: differential effects on follicle-stimulating hormone. Prostate Cancer Hormone therapy for prostate cancer has come a long way in the past few decades. Glossary of Prostate Cancer Related Terms, L - Prostate Cancer LHRH: luteinizing hormone-releasing hormone (also known as GnRH or earlier stages of prostate cancer; LHRH agonist (mimics natural LHRH but then shuts ACS :: Hormone (Androgen Deprivation) Therapy There are several types of hormone therapy used to treat prostate cancer. An anti-androgen may be added if treatment with orchiectomy or an LHRH analog ii. LHRH Agonists - Prostate Cancer Foundation The most commonly used hormone therapy drug class is the LHRH agonists or LHRH analogues. LHRH Antagonist in Prostate Cancer Treatment LHRH antagonist is a type of prostate cancer hormone therapy. LHRH and Prostate Cancer LHRH makes testosterone and is affected by prostate cancer hormone therapy. The use of LHRH agonists in advanced cancer, a page from the The use of LHRH agonists in the treatment of advanced prostate cancer, The clinical effectiveness of LHRH agonists in prostate cancer | The side effects |
| lhrh prostate cancer |
|
outcome prostate radiation treatment new york prostate institute pc3 prostate hyperplasia of the prostate |